Researchers investigated the content validity of patient-reported outcome measures in patients with idiopathic inflammatory myopathies.
Researchers assessed and compared the fracture risk and prevalence of osteoporosis in patients with idiopathic inflammatory myopathy and rheumatoid arthritis.
Authors of a report presented the case of systemic sclerosis-polymyositis overlap syndrome in an adolescent with anti-Ku antibodies.
Experts highlight the need for cancer screening strategies in patients with rheumatic diseases.
Researchers determined whether a modified disease activity score (DAS) correlated with the validated DAS in patients with juvenile dermatomyositis.
Researchers studied growth and puberty in a multinational prospective cohort of children with juvenile dermatomyositis.
A triple steroid/intravenous immunoglobulin/steroid-sparing immunosuppressant induction strategy was effective for the treatment of statin-induced anti-HMGCR myopathy.
Researchers analyzed endothelial biomarker levels in the peripheral blood of patients with juvenile dermatomyositis and their association with disease assessments.
Researchers measured discordance between patient or family and physician global activity scores in juvenile dermatomyositis, and determined factors associated with discordance.
Muscle disease is more prominent among patients with dermatomyositis and anti-Mi2 autoantibodies compared with in those who have anti-Mi2-negative dermatomyositis.